Immediate Impact
1 from Science/Nature 65 standout
Citing Papers
Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
2024 Standout
Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers
2024 Standout
Works of Yan Fu being referenced
Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Yan Fu | 53 | 40 | 6 | 96 | 61 | 33 | 381 | |
| Yujie Zhang | 28 | 7 | 1 | 30 | 24 | 35 | 417 | |
| Qinghua Ren | 58 | 16 | 22 | 131 | 37 | 451 | ||
| Niki Patel | 9 | 28 | 4 | 17 | 71 | 20 | 414 | |
| Yunzhi Lin | 46 | 22 | 3 | 16 | 10 | 25 | 373 | |
| Feng Xu | 15 | 10 | 37 | 43 | 14 | 39 | 440 | |
| Zhiqiong Wang | 33 | 32 | 1 | 26 | 12 | 59 | 431 | |
| Qianying Liu | 21 | 4 | 13 | 19 | 36 | 383 | ||
| Matthias Lehmann | 8 | 42 | 2 | 61 | 180 | 19 | 350 | |
| Jiawei Liang | 54 | 5 | 28 | 5 | 58 | 428 | ||
| Georgios C. Anagnostopoulos | 41 | 22 | 2 | 30 | 15 | 31 | 360 |
All Works
Login with ORCID to disown or claim papers
Loading papers...